Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...
The global drug formulation market is set for remarkable growth, with total sales projected to increase from USD 1.7 trillion in 2025 to a staggering USD 2.8 trillion by 2035. The market is expected ...
Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...
ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R ...
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...
For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. This intricate process, pivotal ...
In the world of drug discovery and clinical trials, drug formulation can make or break a product’s success, yet its role often goes underappreciated, says Christine Allen, cofounder and CEO of ...
Zanubrutinib's new tablet formulation is approved for all five indications, reinforcing its market leadership among BTK inhibitors. The 160 mg tablet simplifies dosing, reducing the daily intake from ...
The precision medicine market is projected to exceed $175 billion by 2030, reflecting continued growth and interest in innovative approaches that tailor therapeutics that accounts for differences in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results